Radiation Therapy in the Management of Leptomeningeal Disease from Solid Tumors

Optimal management of leptomeningeal disease with radiation therapy is an active area of interest. Understanding the current evidence regarding the role of radiation therapy in the management of leptomeningeal disease as well as the types of radiation therapy techniques that have been considered in the management are useful in improving knowledge and skill for clinical practice.

Please visit https://www.advancesradonc.org/article/S2452-1094(23)00205-1/fulltext to read the related journal article online. 

This activity is available from February 15, 2024, through 11:59 p.m. Eastern time on February 14, 2026.

Target Audience

This course is designed to meet the interest of radiation oncologists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the current evidence regarding radiation therapy and its use in the management of leptomeningeal disease.
  • Identify the radiation therapy techniques that have been studied in the treatment of leptomeningeal disease.
  • Determine the clinical considerations for which various radiation therapy techniques (ex. involved field radiotherapy, craniospinal irradiation, etc.) would be considered a reasonable approach for management of leptomeningeal disease.

 

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
02/15/2024
Course expires: 
02/14/2026
Cost:
$49.00
Rating: 
0

Rachel Jimenez, MD is employed by Massachusetts General Hospital and has no financial relationships with a commercial interest. She serves in a leadership position with the American Society of Clinical Oncology and SurvivingBreastCancer.org.

The person(s) above served as the developer(s) of this activity. Additionally, Education Committee had control over the content of this activity.

All relevant financial relationships have been mitigated.

 

 

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$49.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $49
  • Member: $0


Policies:

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until February 14, 2026, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.